Advertisement

Topics

Eylea helps Regeneron smash profit estimates

12:21 EDT 3 Aug 2017 | Reuters

(Reuters) - Regeneron Pharmaceuticals Inc's quarterly profit handsomely beat estimates on strong demand for its flagship Eylea drug, prompting the U.S. drugmaker to raise its full-year growth forecast for the eye treatment.

Original Article: Eylea helps Regeneron smash profit estimates

NEXT ARTICLE

More From BioPortfolio on "Eylea helps Regeneron smash profit estimates"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...